Peer-Reviewed Journal Details
Mandatory Fields
Castano, IM,Curtin, CM,Shaw, G,Murphy, JM,Duffy, GP,O'Brien, FJ
2015
February
J Control Release
A novel collagen-nanohydroxyapatite microRNA-activated scaffold for tissue engineering applications capable of efficient delivery of both miR-mimics and antagomiRs to human mesenchymal stem cells
Published
Optional Fields
MicroRNA Nanohydroxyapatite particles Collagen-based scaffolds Human mesenchymal stem cells Tissue engineering GENE DELIVERY OSTEOGENIC DIFFERENTIATION REPLACEMENT THERAPY RNA INTERFERENCE ADIPOSE-TISSUE DRUG-DELIVERY GAG SCAFFOLDS IN-VITRO PROLIFERATION PEPTIDES
200
42
51
Manipulation of gene expression through the use of microRNAs (miRNAs) offers tremendous potential for the field of tissue engineering. However, the lack of sufficient site-specific and bioactive delivery systems has severely hampered the clinical translation of miRNA-based therapies. In this study, we developed a novel non-viral bioactive delivery platform for miRNA mimics and antagomiRs to allow for a vast range of therapeutic applications. By combining nanohydroxyapatite (nHA) particles with reporter miRNAs (nanomiRs) and collagen-nanohydroxyapatite scaffolds, this work introduces the first non-viral, non-lipid platform to date, capable of efficient delivery of mature miRNA molecules to human mesenchymal stem cells (hMSCs), a particularly difficult cell type to transfect effectively, with minimal treatment-associated cytotoxicity. Firstly, miRNAs were successfully delivered to hMSCs in monolayer, with internalisation efficiencies of 17.4 and 39.6% for nanomiR-mimics and nanoantagomiRs respectively, and both nanomiR-mimics and nanoantagomiRs yielded sustained interfering activity of greater than 90% in monolayer over 7 days. When applied to 3D scaffolds, significant RNA interference of 20% for nanomiR-mimics and 88.4% for nanoantagomiRs was achieved with no cytotoxicity issues over a 7 day period. In summary, in-house synthesised non-viral nHA particles efficiently delivered reporter miRNAs both in monolayer and on scaffolds demonstrating the immense potential of this innovative miRNA-activated scaffold system for tissue engineering applications. (C) 2014 Elsevier B.V. All rights reserved.
10.1016/j.jconrel.2014.12.034
Grant Details
Publication Themes